Search results for: 'part both'

This study provides a comprehensive overview of the commercial market for lung, breast and colorectal cancer medicines responding to both cytotoxic and hormonal therapies. Researched countries are Mexico, Brazil, and Argentina. Included are competitive profiles, distribution network discussions, pricing analysis, drug pipelines, regulatory issues, ...